Stock Research: Carl Zeiss Meditec

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Carl Zeiss Meditec

XTRA:AFX DE0005313704
75
  • Value
    82
  • Growth
    59
  • Safety
    Safety
    77
  • Combined
    94
  • Sentiment
    18
  • 360° View
    360° View
    75
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Carl Zeiss Meditec AG is a medical technology and device company offering solutions for diagnosing and treating ophthalmic diseases. It operates in the medical technology industry, specifically in ophthalmic devices and microsurgery. The company operates in Germany and offers support services. In the last fiscal year, the company had a market cap of $5,249 million, profits of $1,212 million, and revenue of $2,300 million, with 5,730 employees.

more
Index
CDAX
Energy Efficient
Low Waste
Renewables Users
Sound Pay Europe
MDAX
TecDAX
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
82 72 43 31
Growth
59 12 53 57
Safety
Safety
77 79 86 90
Sentiment
18 1 3 70
360° View
360° View
75 22 45 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 19 12 19
Opinions Change
6 15 10 56
Pro Holdings
n/a 8 26 86
Market Pulse
60 25 38 62
Sentiment
18 1 3 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
82 72 43 31
Growth
59 12 53 57
Safety Safety
77 79 86 90
Combined
94 64 82 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
59 39 32 19
Price vs. Earnings (P/E)
73 61 42 22
Price vs. Book (P/B)
81 70 29 36
Dividend Yield
67 54 55 45
Value
82 72 43 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
34 57 63 45
Profit Growth
76 8 26 17
Capital Growth
78 66 81 81
Stock Returns
29 4 31 67
Growth
59 12 53 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
70 62 80 82
Refinancing
75 63 63 53
Liquidity
52 55 67 77
Safety Safety
77 79 86 90

Similar Stocks

Discover high‑ranked alternatives to Carl Zeiss Meditec and broaden your portfolio horizons.

DWS

XTRA:DWS
Country: Germany
Industry: Asset Management & Custody
Size: Large
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: